Literature DB >> 1607324

Quinolones for the treatment of brucellosis.

R Lang1, E Rubinstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1607324     DOI： 10.1093/jac/29.4.357

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  10 in total

1.  In vitro activities of antibiotics alone and in combination against Brucella melitensis at neutral and acidic pHs.

Authors:  M Akova; D Gür; D M Livermore; T Kocagöz; H E Akalin
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

Review 2.  Quinolones for treatment of human brucellosis: critical review of the evidence from microbiological and clinical studies.

Authors:  Matthew E Falagas; Ioannis A Bliziotis
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

3.  Hydrophobic gentamicin-loaded nanoparticles are effective against Brucella melitensis infection in mice.

Authors:  Edurne Imbuluzqueta; Carlos Gamazo; Hugo Lana; Miguel Ángel Campanero; David Salas; Ana Gloria Gil; Elisa Elizondo; Nora Ventosa; Jaume Veciana; María J Blanco-Prieto
Journal:  Antimicrob Agents Chemother       Date:  2013-05-06       Impact factor: 5.191

Review 4.  Optimum treatment of intracellular infection.

Authors:  M Maurin; D Raoult
Journal:  Drugs       Date:  1996-07       Impact factor: 9.546

5.  Human brucellosis in a nonendemic country: a report from Germany, 2002 and 2003.

Authors:  S Al Dahouk; K Nöckler; A Hensel; H Tomaso; H C Scholz; R M Hagen; H Neubauer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-07       Impact factor: 3.267

Review 6.  Endocarditis due to rare and fastidious bacteria.

Authors:  P Brouqui; D Raoult
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

Review 7.  Recognition and optimum treatment of brucellosis.

Authors:  J Solera; E Martínez-Alfaro; A Espinosa
Journal:  Drugs       Date:  1997-02       Impact factor: 9.546

Review 8.  Quinolones in intracellular infections.

Authors:  J C Pechère
Journal:  Drugs       Date:  1993       Impact factor: 9.546

9.  Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis. The GECMEI Group. Grupo de Estudio de Castilla-la Mancha de Enfermedades Infecciosas.

Authors:  J Solera; M Rodríguez-Zapata; P Geijo; J Largo; J Paulino; L Sáez; E Martínez-Alfaro; L Sánchez; M A Sepulveda; M D Ruiz-Ribó
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

10.  Efficacy evaluation of some antibiotics against syrian brucella spp isolates, in vitro.

Authors:  Mazen Safi; Ayman Al-Mariri
Journal:  Braz J Microbiol       Date:  2012-06-01       Impact factor: 2.476
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.